- £299.82m
- £557.92m
- £402.90m
- 47
- 70
- 84
- 79
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 20.27 | ||
PEG Ratio (f) | 0.34 | ||
EPS Growth (f) | 150.77% | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.69 | ||
Price to Tang. Book | 3.18 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 0.74 | ||
EV to EBITDA | 22.32 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -1.06% | ||
Return on Equity | -3.11% | ||
Operating Margin | -1.27% |
Financial Summary
Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | £m | 185.4 | 192 | 315.9 | 381.9 | 402.9 | 312.6 | 317.22 | 25.68% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | -3.06 | -47.38 | +135.31 | -29.24 | n/a | n/a | +49.53 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Marlowe plc is engaged in providing business-critical services which assure safety and regulatory compliance. The Company operates through two segments: Testing, Inspection & Certification (TIC) and Occupational Health (OH). OH segment is engaged in providing a range of occupational health services, which include health surveillance, absence management and employee wellbeing. It offers four groups of service as well as specialist mental health and musculoskeletal health services. Its TIC segment certifies business premises and systems are safe and compliant. From initial design and installation, through to ongoing maintenance and monitoring, it provides a range of services to ensure fire safety, security and compliance with associated safety regulations. It provides water hygiene and treatment and air hygiene services to help manufacturers, commercial businesses and public organizations maintain safe water and air systems and stay compliant with safety and environmental regulations.
Directors
- Last Annual
- March 31st, 2024
- Last Interim
- March 31st, 2024
- Incorporated
- January 14th, 2016
- Public Since
- March 31st, 2016
- No. of Employees
- 5,332
- Sector
- Professional & Commercial Services
- Industry
- Industrials
- Exchange
- London Stock Exchange
- Shares in Issue
- 87,411,523
- Address
- 20 Grosvenor Place, LONDON, SW1X 7HN
- Web
- https://marloweplc.com/
- Phone
- +44 2038138498
- Contact
- Benjamin Tucker
- Auditors
- RSM UK Audit LLP
Latest News for MRL
Upcoming Events for MRL
Half Year 2025 Marlowe PLC Earnings Release
Similar to MRL
ADVFN
London Stock Exchange
Andrews Sykes
London Stock Exchange
Anexo
London Stock Exchange
Ashtead
London Stock Exchange
Ashtead Technology Holdings
London Stock Exchange
FAQ
As of Today at 21:55 UTC, shares in Marlowe are trading at 343.00p. This share price information is delayed by 15 minutes.
Shares in Marlowe last closed at 343.00p and the price had moved by +46.97% over the past 365 days. In terms of relative price strength the Marlowe share price has outperformed the FTSE All Share Index by +33.45% over the past year.
The overall consensus recommendation for Marlowe is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreMarlowe does not currently pay a dividend.
Marlowe does not currently pay a dividend.
Marlowe does not currently pay a dividend.
To buy shares in Marlowe you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 343.00p, shares in Marlowe had a market capitalisation of £299.82m.
Here are the trading details for Marlowe:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: MRL
Based on an overall assessment of its quality, value and momentum Marlowe is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Marlowe is 442.86p. That is 29.11% above the last closing price of 343.00p.
Analysts covering Marlowe currently have a consensus Earnings Per Share (EPS) forecast of £0.13 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Marlowe. Over the past six months, its share price has outperformed the FTSE All Share Index by +54.57%.
As of the last closing price of 343.00p, shares in Marlowe were trading +58.64% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Marlowe PE ratio based on its reported earnings over the past 12 months is 20.27. The shares last closed at 343.00p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Marlowe's management team is headed by:
- Kevin Quinn - NEC
- Alex Dacre - CEO
- Adam Councell - CFO
- Rachel Horsley - NED
- Peter Gaze - NID